EFFECTS OF HIGH CONCENTRATION INSULIN ON THE EXPRESSION OF GLUCOSE TRANSPORTERS IN RENAL TUBULAR EPITHELIAL CELLS

被引:0
作者
Zhang, K. [1 ]
Mu, Y. D. [2 ]
Hao, Y. K. [3 ]
Yan, L. [2 ]
Liu, H. F. [4 ]
Liang, J. [5 ]
Yang, X. F. [6 ]
机构
[1] Harbin Med Univ, Hosp 4, Dept Nephrol, Harbin, Peoples R China
[2] Mudanjiang Med Univ, Dept Histol & Embryol, Mudanjiang, Peoples R China
[3] Mudanjiang Med Univ, Dept Med Funct, Mudanjiang, Peoples R China
[4] Mudanjiang Med Univ, Heilongjiang Key Lab Antifibrosis Biotherapy, Mudanjiang, Peoples R China
[5] Mudanjiang Med Univ, Stem Cell Inst, Mudanjiang, Peoples R China
[6] Mudanjiang Med Univ, Dept Pathophysiol, 3 Tongxiang Rd, Mudanjiang 157011, Heilongjiang, Peoples R China
关键词
insulin; glucose transporter; renal tubular epithelial cells; protein; INDUCED DIABETIC-RATS; INHIBITION; SGLT-2;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:251 / 256
页数:6
相关论文
共 11 条
  • [1] Expression and Activity of SGLT2 in Diabetes Induced by Streptozotocin: Relationship with the Lipid Environment
    Albertoni Borghese, Maria F.
    Majowicz, Monica P.
    Ortiz, Maria C.
    del Rosario Passalacqua, Maria
    Sterin Speziale, Norma B.
    Vidal, Norberto A.
    [J]. NEPHRON PHYSIOLOGY, 2009, 112 (03): : P45 - P52
  • [2] Sodium glucose transporter 2 inhibition: A new approach to diabetes treatment
    Bloomgarden, Zachary
    [J]. JOURNAL OF DIABETES, 2013, 5 (03) : 225 - 227
  • [3] Modeling glucose metabolism and lactate production in the kidney
    Chen, Ying
    Fry, Brendan C.
    Layton, Anita T.
    [J]. MATHEMATICAL BIOSCIENCES, 2017, 289 : 116 - 129
  • [4] Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
    DeFronzo, Ralph A.
    Hompesch, Marcus
    Kasichayanula, Sreeneeranj
    Liu, Xiaoni
    Hong, Ying
    Pfister, Marc
    Morrow, Linda A.
    Leslie, Bruce R.
    Boulton, David W.
    Ching, Agatha
    LaCreta, Frank P.
    Griffen, Steven C.
    [J]. DIABETES CARE, 2013, 36 (10) : 3169 - 3176
  • [5] Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron
    Layton, Anita T.
    Vallon, Volker
    Edwards, Aurelie
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 310 (11) : F1269 - F1283
  • [6] Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus
    Luippold, G.
    Klein, T.
    Mark, M.
    Grempler, R.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (07) : 601 - 607
  • [7] Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes
    Mende, Christian W.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (03) : 541 - 551
  • [8] The effects of transdermal insulin treatment of streptozotocin-induced diabetic rats on kidney function and renal expression of glucose transporters
    Ngubane, Phikelelani Siphosethu
    Hadebe, Silindile Innocentia
    Serumula, Metse Regina
    Musabayane, Cephas T.
    [J]. RENAL FAILURE, 2015, 37 (01) : 151 - 159
  • [9] Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects
    Norton, Luke
    Shannon, Christopher E.
    Fourcaudot, Marcel
    Hu, Cheng
    Wang, Niansong
    Ren, Wei
    Song, Jun
    Abdul-Ghani, Muhammad
    DeFronzo, Ralph A.
    Ren, Jimmy
    Jia, Weiping
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (09) : 1322 - 1326
  • [10] Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?
    Panchapakesan, Usha
    Pegg, Kate
    Gross, Simon
    Komala, Muralikrishna Gangadharan
    Mudaliar, Harshini
    Forbes, Josephine
    Pollock, Carol
    Mather, Amanda
    [J]. PLOS ONE, 2013, 8 (02):